Clinical Trial

Sequential Genicular Nerve Ablation Prior to Geniculate Artery Embolization in Knee Pain

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 1, 2024 (before its estimated March 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate whether performing genicular nerve ablation (GNA) before geniculate artery embolization (GAE) improves pain relief and knee function in patients with chronic knee pain. The main questions it aims to answer are: * Does performing GNA prior to GAE enhance pain relief, as measured by the Visual Analog Scale (VAS), at 3 months post-procedure? * Does the sequential approach improve knee function as assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)? Study investigators will compare two groups to see if the sequential approach (GNA followed by GAE) provides better outcomes compared to GAE alone. Participants will: * Undergo either sequential GNA followed by GAE or GAE alone * Have their knee pain and function assessed at baseline, 1 month, 3 months, and 6 months post-procedure * Complete a structured patient satisfaction questionnaire (PSQ) at 3 months post-procedure * Be monitored for procedure-related adverse events up to 6 months post-procedure,
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-17; most recent amendment 2024-09-29.
Status change: Not Yet Recruiting → Recruiting 2024-09-29
Trial Details
NCT Number NCT06514755
Lead Sponsor Zagazig University
Conditions Chronic Knee Pain, Osteoarthritis
Enrollment 60 participants
Start Date 2024-09-29
Primary Completion 2025-03-30 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-01